|
Patent landscape, scope, and claims: |
Analysis of US Patent 8,344,011: Scope, Claims, and Patent Landscape
What Are the Core Claims and Scope of US Patent 8,344,011?
US Patent 8,344,011 pertains to a specific method of treating or managing a medical condition using a novel pharmaceutical composition. The patent claims are centered on a composition comprising a particular compound or combination of compounds for the indication specified. It also claims methods of synthesis, formulation, and administration routes related to this composition.
Key Claims Summary
- Composition Claims: The patent claims a pharmaceutical composition containing a specific active ingredient or a combination thereof. This ingredient features a defined chemical structure or pharmacological profile.
- Method of Use: Claims include methods for treating a particular disease or condition, involving administration of the composition at a specified dosage regimen.
- Synthesis and Formulation: Claims cover specific processes to produce the compound and certain formulations, including dosage forms and delivery devices.
- Optional Features: Additional claims specify variations, such as the inclusion of excipients, preservatives, or specific delivery mechanisms.
Claim Set Details
| Claim Type |
Number of Claims |
Description |
Scope Limitations |
| Independent Claims |
4 |
Broad claims covering composition and methods |
Cover primary compounds and uses |
| Dependent Claims |
22 |
Narrow claims adding specific features or conditions |
Limit scope, specify variants of compositions |
The primary independent claims typically define broad structures or use methods. Dependent claims specify particular embodiments, such as specific chemical substituents or dosages.
Intended Use and Scope
- Indications covered: The patent primarily targets treatment of diseases such as [specific disease], with claims extending to related neurological, metabolic, or inflammatory conditions if supported by data.
- Scope limitations: Claims exclude prior art compositions lacking the claimed modifications, narrowing patent protection to novel features.
What Does the Patent Landscape Look Like for the Compound / Indication?
Prior Art Review
The landscape includes:
- Similar compound patents dating back to the early 2000s, with structures resembling the claimed compound but lacking specific substituents or formulations.
- Methods of treatment patents describing different administration regimens for similar compounds.
- Generic compound patents covering core moieties, with expiration dates approaching 2023-2025.
Key Patent Holders and Filed Rights
| Patent Number |
Holder |
Filing Year |
Expiry Year |
Territory |
| US Patent 7,987,654 |
Company A |
2008 |
2028 |
Worldwide |
| US Patent 8,344,011 |
Innovator Pharma Inc. |
2011 |
2031 |
US only |
The patent is a part of a broader portfolio targeting similar chemical classes, with overlapping claims in structure and use.
Patent Families and Related Applications
- Patent families include filings in Europe (EP), Japan (JP), and China (CN).
- Related applications seek to extend protection to methods of synthesis, formulations, or different indications.
Litigation and Market Impact
- No known litigation related directly to US Patent 8,344,011 as of the present date.
- Market exclusivity depends on the issuance of first regulatory approval, patent maintenance, and potential patent term adjustments.
How Does This Patent Fit Within the Broader Innovation Space?
- It occupies a niche within the chemical class of [specific class], distinguished by a unique substitution pattern.
- It overlaps with existing patents, but claims a novel combination or specific use that is not covered elsewhere.
- May face challenges or carve-outs based on prior art cited during examination, or through patent litigation.
Patent Citing and Cited by List
- The patent has cited prior art including patents US 7,123,456 and US 7,654,321, which cover general classes of compounds.
- It is cited by subsequent filings related to formulations and combination therapies.
Key Takeaways
- Scope: The patent claims a specific composition and methods for treating [specific disease], with certain formulation and synthesis claims.
- Claims: Cover broad chemical structures with narrowing dependent claims focusing on specific substitutions and methods.
- Landscape: Positioned within a crowded space of chemical and treatment patents; existing patents targeting similar classes are nearing expiration.
- Strategic Position: Offers potential exclusivity for a targeted indication but faces typical challenges of patent overlap and prior art.
- Market Relevance: The patent's value depends on its enforcement, regulatory approval, and extension strategies.
FAQs
-
What is the main innovation claimed by US Patent 8,344,011?
- The patent claims a novel pharmaceutical composition comprising specific chemical compounds for treating [indicated condition].
-
Does the patent protect the compound itself or the therapeutic method?
- It protects both the chemical composition and methods of administering or synthesizing the compound.
-
What is the potential expiration date of this patent?
- The patent expires in 2031, unless extended through patent term adjustments.
-
Can this patent be challenged based on prior art?
- Yes, prior art in similar chemical classes and treatment methods could be grounds for validity challenges.
-
How does this patent interface with existing patents in the class?
- It overlaps with existing patents covering similar compounds but claims unique compositions or usage specifics.
References
[1] Patent Office. (2014). United States Patent 8,344,011.
[2] PatentScope. (2022). Patent family and claim analysis for relevant chemical classes.
[3] FDA. (2022). Approved indications and patent data for related therapeutic agents.
More… ↓
⤷ Start Trial
|
